Lymphocyte development is dependent upon a complex recombination mechanism that assembles variable (V), diversity (D), and joining (J) gene segments to generate an enormous array of clonally distinct B-and T-cell antigen receptors. The V(D)J recombinase is specifically targeted to antigen receptor loci by recognition of highly conserved recombination signal sequences (RSS) that flank the germ line V, D, and J segments (36) . Double-strand DNA breaks (DSB) are introduced between RSS and adjacent coding sequences (50, 52) only in lymphocyte progenitors, because this process requires two recombinase-activating genes, RAG-1 and RAG-2, whose expression is restricted to developing lymphocytes (41, 42, 51, 54) . RAG-1-RAG-2-mediated cleavage at RSS yields asymmetrical products: a blunt signal end and a hairpin-terminated coding end (49, 52, 60, 63) . Several ubiquitously expressed DSB repair activities participate in the resolution of these free ends into coding or signal joints (3, 23, 28, 44, 59) . Thus, V(D)J recombination requires the coordinate action of lymphoid-cell-specific, site-directed components and several ubiquitously expressed DNA repair activities.
The essential connection between DSB repair and V(D)J recombination was first revealed by analyses of the murine scid (severe combined immunodeficiency) mutation. In scid lymphocyte precursors, impaired V(D)J recombination results in T-and B-cell maturational arrest and profound immunodeficiency (7) . Because RSS-specific DSB are introduced normally (4, 37, 39, 50) , it was initially suggested that the scid gene encodes a lymphoid-cell-specific gene required for efficient processing of free coding ends into coding joints (37, 39, 53) . However, subsequent studies demonstrated that nonlymphoid cells in scid mice are hypersensitive to ionizing radiation and other agents which cause DSB (3, 23, 29) . Thus, the scid gene encodes or regulates a DSB repair activity expressed in all cell lineages that also plays an essential role in V(D)J recombination. Additional DSB repair genes that participate in V(D)J recombination were identified by analyses of Chinese hamster ovary (CHO) mutant cell lines that are hypersensitive to ionizing radiation (31, 44, 57, 59) . Defects in scid cells and the CHO cell line V3 both map to the XRCC7 gene and selectively impair coding joint formation (5, 33, 57) . In contrast, mutations in the XRCC4 or XRCC5 gene block the production of both V(D)J signal and coding joints (44, 59) .
Recent studies have identified the products of the XRCC7 and XRCC5 DSB repair genes as subunits of the DNA-dependent protein kinase (DNA-PK) complex. The XRCC7 gene appears to encode the DNA-PK catalytic subunit (DNA-PK cs ) (5, 9, 33, 45) , a 460-kDa serine/threonine protein kinase which belongs to the phosphatidylinositol (PI)-3 kinase family (27) . Several DNA-binding proteins have been shown to be substrates for DNA-PK cs -mediated phosphorylation in vitro, including the transcription factors Sp1, c-jun, c-fos, and Oct-1; the tumor suppressor p53; and the carboxy-terminal domain of RNA polymerase II (2) . A unique feature of DNA-PK cs is that its enzymatic function is active only in the presence of DNA ends, and studies suggest that catalytic activity is enhanced when enzyme and substrate are colocalized to the same DNA molecule (24) . The XRCC5 gene encodes the 80-kDa subunit of the p70/p80 Ku heterodimer (8, 48, 55, 58) , which serves as the DNA end-binding constituent of DNA-PK (24, 47) . Transfection of human Ku p80 cDNA or genomic clones containing DNA-PK cs p460 restored normal DSB repair and V(D)J coding joint formation to the XRCC5 and XRCC7 mutant cell lines, respectively. Thus, mutation of either the p80 or p460 subunit of the oligomeric DNA-PK complex confers hypersen-sitivity to ionizing radiation, as well as defective V(D)J recombination.
Although DNA-PK cs p460 has been clearly implicated as the scid gene, the nature of the mutation that disrupts its function in DSB repair and V(D)J recombination is unknown. Expression of catalytically active DNA-PK cs p460 in scid fibroblast lines was reported to be undetectable (5, 33, 45) , but extensive analyses of the scid defect in V(D)J recombination suggest that it may not derive from a null mutation. For example, the scid mutation is "leaky" (11, 12, 21, 29, 34, 43, 46, 62) , and we have shown that the production of normal T-cell receptor ␤ chain (TCR␤) and TCR␦ coding joints can be induced by low-dose irradiation of newborn scid mice (19, 38) . We have also shown that abrogation of a p53-dependent DNA damage checkpoint in scid lymphocyte precursors prolongs their survival and facilitates the production of normal TCR␤ coding joints (26) , further supporting the idea that the scid mutation in DNA-PK does not ablate its ability to participate in V(D)J recombination. In this study, we have investigated the expression, subcellular localization, and structure of the catalytic domain of DNA-PK cs in immature lymphoid cells from wild-type (WT) and scid mice in an effort to extend our understanding of the crucial relationship between DSB repair and lymphocyte development. Our results support the view that the complex scid phenotype results from the abnormal coordination or regulation of DSB repair processes required to complete coding joint formation during lymphoid development, rather than an absent activity.
MATERIALS AND METHODS
Mice. C.B-17 scid/scid mice (scid mice) were obtained from R. A. Phillips, and mice carrying the RAG-2 null mutation (54) were obtained from GenPharm (Mountain View, Calif.). All animals were maintained under specific-pathogenfree conditions at the Hospital for Sick Children, Toronto, Canada.
Cell lines and radiation survival analyses. VL3-3M2 is a subclone of VL3/B3, C57BL6/Ka radiation leukemia virus-induced thymic lymphoma (TL) which expresses the CD4 and CD8 coreceptors and V(D)J recombinase activity (25) . The cell lines LK3C, LK6.2, and LK8 are independent isolates from 4-to 6-month-old scid mice which had received 100 cGy of 137 Cs radiation at birth and developed TLs (19) . The fibroblast lines CBIII (WT), SCM (scid), and SCC (scid) and Abelson virus-transformed pre-B cell lines GAL 176 (WT) and GAL 178 (scid) were provided by R. Phillips. The CHO cell lines were provided by P. Jeggo and S. Lewis (xrs-6) and by G. Whitmore (AA8.4). All lines were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum, glutamine, 10 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid) (pH 7.0), and 5 M 2-mercaptoethanol. For determination of sensitivity to ionizing radiation, 2 ϫ 10 6 cells were irradiated with a 137 Cs source and assayed for viability 24 h later by trypan blue dye exclusion.
Preparation of protein extracts. Whole-cell extracts (WCE) were prepared by modification of previously described techniques (22) . Cells were washed in phosphate-buffered saline and washed again in hypotonic buffer (HB) (10 mM HEPES [pH 7.2], 25 mM KCl, 10 mM NaCl, 1 mM MgCl 2 , 0.1 mM EDTA) to remove residual phosphate. Cell pellets were resuspended at 2 ϫ 10 7 to 3 ϫ 10 7 cells per 100 l (cell lines) or 5 ϫ 10 7 to 10 ϫ 10 7 cells per 100 l (thymocytes) in HB supplemented with 0.5 mM dithiothreitol (DTT) and protease inhibitors (1 mM phenylmethylsulfonyl fluoride [PMSF], 50 g of betstatin per ml, and 0.5 g each of aprotinin, leupeptin, and pepstatin per ml), frozen on dry ice and thawed at 30ЊC three times, and then adjusted to 0.5 M KCl and 10 mM MgCl 2 with gentle pipetting. Following microcentrifugation for 10 min at 4ЊC, the supernatant was recovered, diluted to 0.1 M KCl by addition of 50 mM HEPES (pH 7.5), and stored at Ϫ80ЊC. For preparation of nuclear extracts (NE) and postnuclear extracts (PNE), cells were allowed to swell on ice for 15 min in 10 mM HEPES (pH 7.9)-10 mM KCl-0.1 mM EDTA-1 mM DTT and protease inhibitors at a concentration of 2 ϫ 10 7 cells per ml (cell lines) or 5 ϫ 10 7 to 10 ϫ 10 7 cells per ml (thymocytes). Samples were lysed by addition of Nonidet P-40 (NP-40) to a final concentration of 0.6%, followed by vortexing, and microcentrifuged for 30 min at 4ЊC. The supernatant was reserved and referred to as the PNE, and the pellet was resuspended in 20 mM HEPES (pH 7.9)-400 mM KCl-1 mM EDTA-1 mM DTT and protease inhibitors and rocked for 15 min at 4ЊC. The NE were recovered by microcentrifugation for 10 min and adjusted to 120 mM KCl by addition of 10 mM HEPES (pH 7.9) containing protease inhibitors. PNE and NE samples were stored at Ϫ80ЊC.
PAGE and Western blotting (immunoblotting).
Proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (6% polyacrylamide; cross-linking ratio, 100:1) under standard conditions and transferred to nitrocellulose membranes (Bio-Rad) at a constant voltage (2 h at 60 V or overnight at 20 V) in 20 mM Tris-Cl-150 mM glycine-20% methanol (pH 8.0). The DNA-PK cs was identified by reaction of Western blots with hybridoma supernatant containing anti-human DNA-PK cs antibodies 18-2 and 42-27 (13), followed by enhanced chemiluminescence (ECL) according to the kit manufacturer's instructions (Amersham). The retinoblastoma protein (pRb) was identified by incubation of Western filters in 1 g of monoclonal antibody G3-245 (Pharmingen, San Diego, Calif.) per ml, followed by ECL. All primary antibodies were detected with anti-mouse immunoglobulin G (IgG) coupled to horseradish peroxidase (Jackson Immunoresearch Labs, Inc., West Grove, Pa.). Densitometry was performed by using Quantity One PDI software on a Sun Microsystems workstation.
Protein fractionation by dsDNA binding. Fractionation of WCE, PNE, and NE proteins by binding to double-stranded DNA (dsDNA)-cellulose was performed essentially as previously described (22) . To ensure removal of DNAassociated protein contaminants, the dsDNA-cellulose (Sigma) was preswollen in ZЈ 0.05 (25 mM HEPES [pH 7.9], 50 mM KCl, 10 mM MgCl 2 , 1 mM DTT), washed twice in high-salt ZЈ 0.4 (ZЈ 0.05 with 0.4 M KCl instead of 50 mM KCl) containing 0.5% NP-40, and then reequilibrated by three washes in ZЈ 0.05 prior to use. Fifty to 100 g of protein extract was incubated with 20 l of dsDNAcellulose at 4ЊC for 15 min with gentle agitation, and the protein-DNA-cellulose complexes were washed twice in ZЈ 0.05. For direct analysis of dsDNA-binding proteins, the complexes were resuspended in SDS sample buffer, heated to 90ЊC for 2 min, and analyzed by SDS-PAGE.
Kinase assays. For functional assays, 50 to 100 g of WCE protein was incubated with dsDNA-cellulose and washed with ZЈ 0.05 buffer as described above. We measured the ability of DNA-PK cs to phosphorylate serine residues in the transactivation domain of p53 as previously described (35) and by using DNA-PK cs immobilized on dsDNA-cellulose beads (22) . WCE DNA-cellulose complexes were resuspended on ice in 30 l of kinase buffer {25 mM HEPES [pH 7.9], 50 mM KCl, 10 mM MgCl 2 , 0.5 mM EGTA [ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid], 0.1 mM EDTA, 5% glycerol, 0.5 mM DTT, and protease inhibitors}. To assemble the reaction mixtures, the slurry was divided into two prechilled microcentrifuge tubes on ice, containing ATP (final concentration, 50 M), [␥-
32 P]ATP (3,000 Ci/mmol; 10 Ci per reaction), and 4 nmol of either the WT p53 peptide (EPPESQEAFADLWK-K) or a mutant form lacking the consensus phosphorylation site (EPPLSEQAFA DLWK-K) (35) . The tubes were then incubated at 30ЊC for 10 min, and the reactions were quenched by addition of ATP to 10 mM and EDTA to 25 mM. The reaction mixture was microcentrifuged for 10 s, and the supernatant was transferred to a fresh tube containing an equal volume of 30% acetic acid. Duplicate portions of each reaction mixture were spotted on Whatman P-81 phosphocellulose paper, the paper was washed three times in 15% acetic acid, and the bound radioactivity was determined from Cherenkov radiation as previously described (35) . Blank values were obtained from mock kinase reaction mixtures containing dsDNA-cellulose without WCE proteins.
Molecular cloning and analyses. RNA for analysis of p460 was prepared by emulsification of cells in guanidine thiocyanate solution, followed by phenolchloroform extraction and centrifugation through cesium chloride (17) . Degenerate oligonucleotide primers flanking the presumptive catalytic domain were designed by using the human p460 cDNA sequence (GenBank accession no. U34994) (27) . Ten micrograms of total RNA from tissue culture cells or fresh thymocytes was reverse transcribed as previously described (18) with inclusion of antisense primer DPK3 (CAT CCA ZGG C/TTC CCA TCC C/TTC CCA, where Z ϭ A, C, G, or T and C/T is a 1:1 mixture) at a final concentration of 0.5 M. The cDNA was amplified with DPK1 (CCG CCZ TGT GAA/G TAC/T AAA/G GAC/T TGG, where C/T or A/G is a 1:1 mixture) and DPK3 by three cycles of 94ЊC for 30 s, 45ЊC for 1 min, and 72ЊC for 1 min followed by 27 cycles of 94ЊC for 30 s, 58ЊC for 1 min, and 72ЊC for 1 min in a Perkin-Elmer 480 thermal cycler. Amplified p460 kinase domain fragments were gel purified, cloned into the pTA vector (Invitrogen Corp.), and transformed into Escherichia coli. Multiple pTA clones derived from independent reverse transcriptase PCRs (RT-PCRs) from each cell source were sequenced on both strands by dideoxy chain termination, and sequence data were analyzed by using DNAsis software (Allelix Pharmaceuticals, Inc.). Sequencing primers included the universal forward and reverse primers (United States Biochemicals); internal forward primers DPK8 (TGG CTG GTG AAA GTG TCG GGG), DPK4 (TGT AAA GAT GAG CAC CAG CC), and DPK7 (ATG GTG CAT GCA CTG AGG GC); and internal reverse primer DPK6 (AGT CCT GCC AAG GAT ATT GG). For Northern (RNA) blot analysis, 10 g of total RNA was resolved on a 1% denaturing agarose gel, transferred to nylon membrane, and hybridized with the wild-type kinase domain probe by standard methods. The same membrane was then evaluated with a rat ␤-actin cDNA probe. Phosphorimages were obtained by using the Molecular Dynamics imaging system and Image Quant software.
RESULTS
Impact of the scid mutation on expression of DNA-PK cs p460 in different cell lineages. Since the scid mutation reveals an essential connection between generalized DSB repair and the exclusively lymphoid V(D)J recombination process, we were interested in studying the DNA-PK complex in WT and scid immature lymphoblasts. We had previously shown that newborn scid mice treated with a single low dose of ionizing radiation invariably develop TLs by 4 to 6 months of age (19) . Adaptation of multiple scid TLs to continuous culture provided clonal, CD4
ϩ CD8 ϩ double-positive thymocyte lines for the analysis of DNA-PK cs in the context of immature lymphocytes. To determine whether these TL cell lines retained the radiation sensitivity characteristic of the scid mutation, we compared the viable cell recovery rates of WT and scid TL and immature B-cell lines following irradiation with 100 or 300 cGy (Table 1) . At both radiation doses, survival of the scid TL cell lines was substantially reduced relative to that of a WT TL (VL3-3M2) of an equivalent maturational stage (25) . Similarly, the immature scid pre-B cell line GAL 178 was more radiosensitive than GAL 176, a WT pre-B cell line. These results suggested that these immature lymphoid cell lines were suitable for study of DNA-PK cs expression and function in the context of the scid phenotype.
Monoclonal antibodies raised against purified human DNA-PK cs p460 protein (13) were tested for cross-reactivity on the murine protein. The 18-2 antibody recognizes an epitope in the N-terminal 240 kDa of p460, whereas 42-27 reacts with an epitope found in the C-terminal 150 kDa (14, 56) . WCE proteins from the human T-lymphoma cell line Jurkat and the WT murine TL line VL3-3M2 were compared by Western blot analysis using these two monoclonal antibodies (Fig. 1A) . Each reagent detected a murine protein that comigrated with the human p460 (Fig. 1A) . Similar results have been described for WT rodent fibroblast lines (33, 45) . Densitometric analysis suggested that Jurkat cells express about 5-to 10-fold more p460 than VL3-3M2 ( Fig. 1A and data not shown).
In addition to murine p460, both antibodies detected a novel protein species of approximately 220 kDa (p220) in murine VL3-3M2 cells which was absent from the Jurkat line. The 18-2 . In addition to the p460 protein detected in human and murine cells, both antibodies detected a ϳ220-kDa murine species. Densitometry values for digitized ECL bands (values in lower boxes) are shown for p460 and p220 and were adjusted to reflect the higher level of loading of VL3-3M2. In all experiments, values were normalized to the VL3-3M2 p460 band, which was assigned a value of 1.0 for comparative purposes. (B) Western blot analysis of proteins released from the indicated cells by boiling in SDS-PAGE sample buffer. Five million cell equivalents were loaded for each sample: fresh C57BL/6 thymus (Thy) and bone marrow (BM), VL3-3M2, and four scid TL cell lines (LK3C, -6.2, and -8 and SCTL-2). This and all subsequent Western blotting experiments were done with an equal mixture of 18-2 and 42-27 antibody supernatants. Densitometric data are shown in the boxed region and are based upon a VL3-3M2 signal defined as 1.0. DP, double positive; SC, scid. and 42-27 antibodies had slightly different degrees of p220 reactivity and were used together in most experiments, except as indicated below. p220 was also detected in freshly isolated WT bone marrow cells and thymocytes (Fig. 1B) , arguing that its expression is not a consequence of in vitro selection of transformed cell lines. Recent studies have shown that apoptotic stimuli activate interleukin-1␤-converting enzyme (ICE)-like proteases to cleave human p460 into 240-and 150-kDa fragments (14, 15, 56) . Thus, we sought to determine whether p220 might represent an apoptotic cleavage fragment of rodent p460. To prevent proteolysis from occurring during cell handling and extract preparation, equal numbers of WT and scid cells were lysed by boiling in SDS sample buffer and the soluble fraction was immediately loaded onto SDS-PAGE gels and evaluated by Western blotting. Under these lysis conditions, both p460 and p220 were present in VL3-3M2 at the levels seen in WCE preparations, suggesting that the p220 protein was not generated during sample preparation (Fig. 1B) . Although p460 was reported to be absent or barely detectable in scid fibroblasts (33, 45), we readily detected p460 protein in all scid TL cell lines examined (Fig. 1B) . In these cell lines, densitometric analyses showed that p460 was expressed at 1 to 10% the level seen in a WT TL cell line. Similarly, we detected p460 expression in a scid pre-B cell line (GAL 178) at about 10% the level seen in a WT pre-B cell line ( Fig. 2A) . Thus, the scid mutation decreases the abundance, but does not ablate expression, of p460 in lymphoblasts. However, the p220 protein was detectable at WT levels in scid TL cell lines (Fig.  1B) , pre-B cells ( Fig. 2A) , and fibroblasts (Fig. 2B) , suggesting that p220 expression is not impaired by the scid mutation in DNA-PK cs .
In contrast to the situation with lymphoblasts, detection of p460 and p220 expression in equivalent amounts of WCE protein from WT fibroblasts was difficult and required prolonged exposure of the immunoblots ( Fig. 2A and B) . Densitometric analyses confirmed that WT fibroblasts express at least 10-fold less p460 than that seen in WT TL cell lines (data not shown). We found that expression of p460 in fibroblast cell lines from scid mice was barely detectable even after lengthy exposure times, in accord with recent studies (33, 45) . These results suggest that immature lymphocytes express considerably more p460 and p220 than do fibroblasts.
The CHO cell line, V3, exhibits defects in V(D)J recombination and x-ray sensitivity similar to those seen in scid cells. The V3 defects also map to the XRCC7 gene encoding DNA-PK cs (5, 33, 57) . Western blot analysis with the 18-2 and 42-27 antibodies was used to compare p460 expression in WT murine cells (VL3-3M2) with that in CHO cell lines AA8.4 (WT), V3, and xrs-6 (XRCC5) (Fig. 2C) . The CHO cell lines also expressed a p460-cross-reactive protein slightly larger than murine p220 (Fig. 2C) , which we refer to as hamster p220 (Hp220). Although p460 was easily detectable in AA8.4 and xrs-6 CHO cells, it was undetectable in V3 (Fig. 2C) . Thus, the murine (scid) and hamster (V3) XRCC7 mutations have distinct effects on p460 expression.
Differential nuclear association of DNA-PK cs in scid and WT cells. Since nuclear localization of DNA-PK cs is presumably required for DNA-dependent enzymatic function, we investigated the cellular localization of p460 and p220 in WT and scid lymphocytes. This investigation could not be readily achieved by immunofluorescence microscopy with the anti-DNA-PK cs antibodies 18-2 and 42-27, since this technique would not distinguish signals derived from p460 versus p220. Therefore, we evaluated biochemically fractionated protein extracts for expression of DNA-PK cs . Cells were allowed to swell in HB and lysed in 0.6% NP-40, and the PNE were recovered following centrifugation. NE were prepared by high-salt elution of the pelleted nuclear material, and both fractions were examined for DNA-PK cs expression by Western blotting. Surprisingly, in WT TL cell lines, p460 was equally distributed between the PNE and NE fractions (Fig. 3A) . However, in scid TL cell lines, p460 was observed only in the PNE fraction. This does not appear to reflect a generalized disturbance in nuclear protein associations caused by the scid mutation, since the pRb nuclear protein was found exclusively in the NE fraction in both WT and scid cells (Fig. 3A, bottom) . To confirm these data by using nontransformed cells, we examined NE and PNE fractions from freshly isolated WT and scid thymocytes (Fig. 3B) . Thymocytes from RAG-2-deficient mice were also evaluated, since the absence of RAG-2 protein impairs V(D)J recombination and causes arrested thymocyte development similar to that caused by the scid mutation (54) but does not affect DNA repair. Although RAG-2 Ϫ/Ϫ thymocytes expressed slightly less p460 than WT thymocytes, it was distributed equally between the NE and PNE fractions, whereas scid thymocytes expressed greatly reduced levels of p460 that were detected only in the PNE fraction. Expression of p220 was slightly reduced in both RAG-2 Ϫ/Ϫ and scid thymocytes relative to that in WT thymocytes, but in all three genotypes p220 was entirely retained in the nuclear fraction ( Fig. 3A and B) . In RAG-2 Ϫ/Ϫ thymocytes, we observed an additional ϳ240-kDa band (Fig. 3B) which likely represents the murine version of an apoptotic cleavage fragment of p460 recently described for human cells (14, 15, 56) .
Immunofluorescence studies of p460 have demonstrated that it is entirely nuclear in intact cells (13, 45) . To determine whether our detection of p460 in the cytosolic PNE fraction might be caused by detergent-mediated extraction of the protein from the nucleus, subcellular fractionations were repeated by substituting either digitonin or detergent-free Dounce homogenization for NP-40 lysis. Digitonin emulsifies cholesterol residues, which comprise a much higher percentage of the plasma membrane than of the nuclear envelope, causing relatively little nuclear disruption, in contrast to standard nonionic detergents like NP-40, which can promote leaching of nuclear proteins (1). Similar to our observations with NP-40 lysis, WT p460 was equally partitioned between the PNE and NE fractions of digitonin and detergent-free Dounce extracts, whereas scid p460 was found in the PNE under all extraction conditions (data not shown). Therefore, the presence of p460 in the PNE fraction was not explained by a detergent artifact. Rather, these results suggest that WT cells contain two distinct p460 pools that differ in the strength of their tethering to nuclear components, whereas scid cells appear to lack a tightly associated nuclear p460 pool.
We considered impaired binding of p460 to DNA as a potential cause for altered nuclear association of scid p460. DNA binding is required for DNA-PK catalytic activity and is a unique feature of this serine/threonine kinase. We asked whether the p460 and p220 proteins detected by anti-DNA- FIG. 3 . The scid mutation is characterized by altered nuclear association of p460. Cellular localization of DNA-PK cs in scid and WT cells was examined by separating nuclear and cytosolic proteins. Cells were lysed under hypotonic conditions in 0.6% NP-40, and cytosolic extracts (PNE) and NE were prepared as described in Materials and Methods. (A) Fifty-microgram amounts of PNE and NE protein from VL3-3M2 (WT TL) and three scid TL (LK3C, LK6.2, and LK8) were analyzed by Western blotting with anti-DNA-PK cs antibodies 18-2 and 42-27. The lower section of the Western filter was reacted with an antibody to the retinoblastoma nuclear protein (pRb, arrow) without stripping the membrane. (B) NE and PNE from freshly isolated C57BL/6 (WT), RAG-2 Ϫ/Ϫ , or scid thymocytes were immunoblotted with antibody 18-2. (C) dsDNA binding by WT and scid DNA-PK cs proteins. NE and PNE were prepared from a WT and two scid TL cell lines. The extracts were mixed with dsDNA-cellulose beads and washed three times in ZЈ 0.05 buffer, and the bound proteins were removed by boiling in SDS sample buffer. Western blots were probed with antibodies 18-2 and 42-27 and then subjected to ECL. VOL. 16, 1996 MOLECULAR DEFECTS IN scid DNA-PK 5511 PK cs antibodies in WT and scid lymphocytes could bind dsDNA. WT and scid NE and PNE fractions were incubated with dsDNA covalently coupled to cellulose beads by using a recently described "DNA pull-down assay" (22) . After repeated washing of the DNA beads to remove unbound proteins, the DNA-associated proteins were eluted by boiling in SDS sample buffer and analyzed by SDS-PAGE and Western blotting. Both the p460 and p220 from WT and scid cells bound DNA beads (Fig. 3C) , and neither scid p220 nor scid p460 was detected in the unbound fraction (data not shown). Thus, the scid mutation does not impair p460 binding to DNA, suggesting that the catalytic subunit can interact with the Ku heterodimer. Kinase activity of DNA-PK in scid cells. Using a DNA pulldown assay optimized to detect rodent DNA-PK activity, prior studies have failed to detect DNA-PK-mediated phosphorylation of a p53 peptide substrate by WCE extracts from scid fibroblasts (5). Since we detected considerably more p460 protein in scid lymphoblasts than fibroblasts, we used this dsDNA pull-down approach to reevaluate DNA-PK activity in scid lymphoma cell lines. Equal quantities of WCE protein from Jurkat, VL3-3M2, and two scid TL cell lines were immobilized on dsDNA beads and mixed with the normal (WT) p53 peptide or a mutant peptide lacking the consensus phosphorylation site (mock) in a reaction mixture containing [␥-
32 P]ATP. Similar to what was observed in a prior study of nonlymphoid cells (22), we observed five-to sixfold greater radiolabelling of the p53 peptide with WCE protein from WT human than from WT murine lymphocytes (Fig. 4) . In contrast, WCE protein from two different scid TL cell lines displayed no detectable kinase activity for the WT p53 peptide. The failure to detect phosphorylation of this human p53 peptide by scid DNA-PK was also a property of nonlymphoid cells (5) . However, the activity of WT murine DNA-PK was only three-to fourfold above background in this assay (Fig. 4) (22) . Thus, this assay may not be sufficiently sensitive to detect catalytic activity from the reduced levels of p460 protein in scid lymphoblasts.
Analysis of p460 transcripts in WT and scid cells. Our data showed that p460 protein expression in scid cells was reduced by greater than 10-fold compared with expression in WT cells of the same lineage. One possible explanation for our observations was that the scid mutation perturbs p460 gene transcription. To examine steady-state p460 mRNA levels, we designed degenerate oligonucleotide primers based upon the human p460 sequence (27) and performed RT-PCRs to amplify an 880-bp fragment of the C-terminal kinase domain from WT murine thymus. This region is well conserved between human DNA-PK cs and other members of the PI-3 kinase family (27) , and cloning and sequencing of the murine PCR product demonstrated very strong sequence similarity with the human kinase domain (see below). Using this murine kinase domain probe to evaluate Northern blots of human, WT mouse, and scid mouse RNAs, we observed a single, large mRNA species which apparently had the same mobility in all samples (Fig. 5A) . Reanalysis of this Northern filter with a ␤-actin probe confirmed equal loading of the samples, demonstrating that the scid mutation does not appear to alter steady-state p460 mRNA levels. We could not rule out the possibility that the scid mutation confers a slight alteration in mRNA size which is not detectable by Northern blot analysis.
Comparative sequence analysis of WT and murine p460 C-terminal domains. As described above, scid p460 catalytic activity was not detectable in the DNA pull-down assay using a p53 peptide substrate. We could not resolve whether the assay was insufficiently sensitive to detect activity by the reduced p460 protein levels in scid cells or whether the scid mutation affects kinase activity by altering the structure of the p460 kinase domain. To investigate the latter possibility, we used a degenerate RT-PCR strategy to clone and sequence the p460 C-terminal kinase domain from scid thymus and two independent scid TL cell lines (LK3C and LK6.2) (19) (Fig. 5B) . The deduced amino acid sequences of the human and WT mouse kinase domains were 86% identical, and 20 of the 42 residue substitutions were conservative. Both the DRXXXN and DFG motifs thought to be important in catalysis by PI-3 kinase family members (30) were absolutely conserved between human and mouse p460.
Interestingly, comparison of the WT murine and scid kinase domain sequences revealed a single nucleotide difference, changing a tyrosine codon to an ochre premature stop codon in the scid kinase domain 83 amino acids from the normal C terminus of the p460 open reading frame (Fig. 5B) . This Tto-A transversion was confirmed by sequencing RT-PCR products isolated from two independent scid cell lines and from fresh scid thymocytes. This ochre mutation is predicted to truncate the extreme C terminus of the kinase domain by approximately 8 kDa but leaves intact each of the highly conserved catalytic motifs. We had noted a slight mobility difference between the WT and scid p460 proteins in multiple SDS-PAGE experiments (Fig. 2A , compare first lane with second and third lane with fourth). This was verified by coelectrophoresis of mixed WT and scid extracts in a single lane, which clearly resolved two bands, whereas only a single species was visible in each individual extract (Fig. 5C) . The slightly smaller species in the scid extract is consistent with a molecular mass reduction of approximately 8 kDa, a difference of less than 2% of the total p460 mass. Together these results suggest that an ochre mutation in the scid allele yields a slightly truncated form of the DNA-PK cs protein. FIG. 4 . DNA-PK cs -mediated phosphorylation of an N-terminal serine-containing p53 peptide is undetectable in scid cells. One-hundred-microgram amounts of WCE protein from human (Jurkat), scid (LK3C and LK6.2), and WT (VL3-3M2) murine cells were fractionated on dsDNA-cellulose beads, and the bound protein was assayed for kinase activity by using p53 peptide substrates. Equal numbers of WT and scid TL cells yielded very similar amounts of WCE protein, but the larger Jurkat cells yielded two to three times more WCE protein per cell. [␥-
32 P]ATP incorporation into a normal (WT) (s) and serine-deficient (mock) (3) p53 peptide was quantitated. Specific incorporation was calculated as the difference between phosphorylation rates for WT and mock peptides. The specific incorporation values shown are averages for three sets of reactions. 
DISCUSSION
Biochemical abnormalities in scid DNA-PK cs (p460). We have found that scid lymphocyte precursors express readily detectable amounts of DNA-PK cs p460, but the levels seen in this study represented 1 to 10% of the amount in WT lymphocyte precursors (Fig. 1 to 3) . However, we showed that there is substantial quantitative variation in different cell lineages: immature WT and scid lymphocytes express greater amounts of p460 than fibroblasts do. This may explain why in several recent studies of scid fibroblast cell lines, p460 was either not detected (5, 45) or detected only after very long exposures of Western blots (33) . We demonstrate here that steady-state levels of the 13-kb DNA-PK cs mRNA are equivalent in WT and scid cells (Fig. 5A) , arguing that the small amount of p460 protein in scid cells is not due to a transcriptional defect.
We show that in addition to leading to decreased abundance, the scid mutation alters nuclear association of p460. Following hypotonic lysis without detergent or in low concentrations of NP-40 or digitonin, WT p460 partitioned equally between the cytosolic and nuclear fractions. In contrast, the p220 protein did not display this differential partitioning and was found exclusively in the high-salt nuclear eluate from both WT and scid cells. Strikingly, p460 protein from scid cells was detected only in the PNE (Fig. 3) . Since immunofluorescence FIG. 5 . Molecular genetic analysis of WT and scid p460. (A) Northern blot analysis of total RNA prepared from human (Jurkat), WT mouse (VL3-3M2 and BALB/c thymus), and scid mouse (LK3C) T cells with a probe from the 3Ј kinase domain. RNA was resolved on denaturing agarose gels, transferred to nylon membranes, and hybridized to a murine p460 probe generated by RT-PCR with degenerate primers specific to the human sequence (see Materials and Methods). A phosphoimage was collected following overnight exposure, and the membrane was rehybridized to a rat ␤-actin probe. (B) Amino acid sequences of the p460 C-terminal kinase domain from WT and scid mice. cDNA segments corresponding to the C-terminal kinase domain of the human p460 sequence were cloned from WT and scid cells by using a degenerate RT-PCR strategy (see Materials and Methods). An alignment of the translated murine and human sequences is shown. Over this 294-amino-acid region, human and WT mouse sequences were 86% identical (black residues) and 20 of the 42 amino acid substitutions (white residues) were charge conservative (designated ϩ). The dark bars overlie residues within the highly conserved PI-3 kinase catalytic motifs (30) . Residues within the two white boxes are those encoded by the degenerate PCR primers DPK1 (N terminus) and DPK3 (C terminus) as described in Materials and Methods. For comparison with the WT, the scid p460 sequence was determined from fresh thymocytes and two independent TL cell lines (LK3C and LK6.2). Only one difference between WT and scid sequences was found, a T-to-A transversion which caused an ochre mutation and premature stop codon (indicated with a ‫.)ء‬ This mutation predicts a truncation of the extreme C-terminal 83 amino acids of the scid protein. (C) WT p460 and scid p460 exhibit different SDS-PAGE mobilities. PNE from WT VL3-3M2 cells (5 g), WCE (150 g) from scid cells (LK3C) (SC), and a 1:30 mixture of the WT and scid extracts (5 plus 150 g) were resolved by SDS-PAGE and Western blotting. The observed p460 mobility difference is consistent with an approximately 8-kDa reduction in molecular weight due to the C-terminal ochre mutation. This mobility difference was also visible in WT and scid TL and pre-B cell lines (Fig. 2A , compare first and second lanes with third and fourth lanes).
VOL. 16, 1996 MOLECULAR DEFECTS IN scid DNA-PK 5513 on February 23, 2013 by PENN STATE UNIV http://mcb.asm.org/ studies suggest that WT p460 protein is localized exclusively to the nucleus in WT human and murine cells (13, 45) , our data suggest that WT p460 exists in two pools which differ in their degree of tethering to nuclear components. Other nuclear proteins which display differential tethering to the nucleus include the estrogen receptor, which is easily extractable from the nucleus when not bound to hormone but which converts to a stably nucleus-associated form after ligand binding (32, 61) . Our observation that scid cells lack a high-salt-extractable nuclear pool of p460 may indicate that the scid mutation prevents p460 from becoming stably associated with the nucleus. Alternatively, the scid mutation may impair translocation of p460 from the cytoplasm into the nucleus. Since p460 (isolated from NE and PNE fractions) from both genotypes bound DNA, we conclude that the scid mutation does not disrupt interactions between p460 and Ku. Recent studies have shown that apoptotic stimuli activate ICE-like proteases to cleave human p460 into 240-and 150-kDa fragments reactive with the 18-2 and 42-27 monoclonal antibodies, respectively (14, 15, 56) . We also detected these 240-and 150-kDa proteins in RAG-2-deficient thymocytes, in scid thymocyte PNE after prolonged exposure ( Fig. 3B and data not shown), and in WT thymocytes subjected to apoptotic stimuli (17a) . The presence of apoptosis-associated p460 cleavage products in freshly isolated scid thymocytes is consistent with our recent demonstration that these cells undergo p53-dependent apoptosis in vivo (26) . This raises the possibility that the greatly reduced p460 level in scid thymocytes is a secondary effect of apoptosis, rather than a primary feature of the scid mutation. Several points argue against this notion. First, RAG-2-deficient thymocytes are also thought to undergo apoptosis in vivo because they cannot mature into CD4-and CD8-double-positive cells (54) . The presence of a prominent antibody 18-2-reactive 240-kDa protein, presumably a p460 cleavage fragment, is consistent with this notion, but, in contrast to scid thymocytes, p460 is only slightly reduced in RAG-2-deficient relative to WT thymocytes. Second, p460 levels are 1 to 10% WT levels in transformed scid TL and fibroblast cell lines which are not apoptotic (unless treated with DNA-damaging agents). Thus, the severe reduction in p460 seen in scid cells appears to be independent of apoptotic cleavage.
Identification of p220 as a novel, possibly p460-related DNA-binding protein. Two antihuman DNA-PK cs antibodies also reacted with a novel protein species which we designated p220. This protein was detected in murine lymphocytes, bone marrow, and fibroblasts ( Fig. 1 to 3) , and a slightly larger version was detected in CHO cells. Surprisingly, p220 was not detected in two recent studies which used monoclonal antibodies 18-2 and 42-27 to evaluate p460 expression in WT and scid fibroblasts. However, in one study, the Western filter was cut at the 220-kDa marker to permit evaluation of the lower-molecular-weight proteins with a control antibody (33) , potentially obscuring the anti-DNA-PK cs -reactive p220 species. In the other study, p460, but not p220, was observed in detergent-free hypotonic cell extracts (45) but WCE and NE were not evaluated. Thus, these observations agree with our finding that under similar lysis conditions, p220 remains in the nuclear pellet and is only released by high-salt extraction (Fig. 3) . We conclude that different experimental conditions allowed us to visualize p220. p220 is clearly distinct from the putative 240 kDa apoptotic fragment of p460 (Fig. 3B) . Interestingly, however, p220 is somewhat less abundant in apoptotic thymocytes (Fig. 3B) , and it rapidly disappears from WT and scid thymocytes and cell lines after treatment with ionizing radiation (17a). However, in most experiments, p220 was equally abundant in WT and scid TL cell lines. These observations suggest that p220 abundance is not directly affected by the scid mutation but, like p460, p220 may be targeted for rapid proteolytic cleavage in apoptotic cells. We have no direct evidence that p220 is a product of the DNA-PK cs gene. Nonetheless, the reactivity of p220 with two antibodies directed against widely separated epitopes of human p460 (13, 56) , its capacity to bind dsDNA (Fig. 3C) , and its rapid disappearance from apoptotic cells suggest that it may be a p460-related protein.
An ochre mutation in the PI-3 kinase domain of scid DNA-PK cs . To determine whether the apparent lack of DNA-PK activity in scid fibroblasts (5, 9, 45) and lymphoblasts (Fig. 4) might be due to a structural defect in the p460 catalytic domain, we cloned and sequenced most of this region from WT and scid thymocytes and TL cell lines. Sequence comparisons revealed the presence of an ochre mutation predicted to truncate the C terminus of scid p460 by 83 amino acids. This genetic lesion is consistent with our biochemical observation that scid p460 migrates more rapidly than WT p460 on SDS-PAGE gels (Fig. 5C) .
To consider the possible impact of the 83-amino-acid truncation on p460 catalytic activity, it is instructive to compare the PI-3 kinase domains of p460 with those of other members of this family, which can be divided into two subgroups. One subgroup comprises conventional PI-3 kinases, such as p110 and Vps34, proteins that function as lipid or protein kinases in cytoplasmic signal transduction cascades. Members of the second subgroup include DNA-PK, AT, and MEC-1, very large proteins (Ͼ200 kDa) thought to be involved in DNA damage surveillance. DNA-PK is the only member of this subgroup demonstrated to possess catalytic activity, and it functions as a protein serine/threonine kinase rather than a lipid kinase (27) . We show here that like human p460 and other members of this family, murine p460 contains highly conserved DRXXXN and DFG motifs (Fig. 5B ) that are essential for catalytic function in human p110 (20) . The ochre mutation we describe truncates p460 over 100 amino acids beyond these motifs, suggesting that catalytic activity may be retained in the mutant protein. We cannot rule out the presence of additional mutations in the scid p460 sequence located at a region N terminal to the region examined. However, we have not detected any smaller antip460 cross-reactive species in scid cells which are absent from WT cells. Given the spontaneous origin of the scid mutation (7), we view it as unlikely that a second independent genetic lesion is present in p460. However, if another mutation(s) exists in the scid p460 allele, it does not appear to terminate translation at a site N terminal to that of the ochre mutation reported here.
To gain further insight into the potential impact of the ochre mutation, we aligned the truncated 83 amino acids with the analogous regions of human AT, yeast MEC-1, human p110, and yeast Vps34 (Fig. 6 ). Region A depicts residues for which a related segment is present in both the conventional PI-3 kinases and the DNA damage surveillance group. Strikingly, neither the amino acid sequence nor the length of this region is highly conserved, even among members of the DNA damage surveillance subgroup. This suggests that sequences in region A may not be essential for conserved functions of these proteins. By a similar argument, since residues in region B are absent from conventional PI-3 kinases, they are unlikely to be essential for catalytic activity of the DNA damage surveillance proteins. However, within this subgroup, the length of region B is absolutely conserved and there is a high degree of amino acid sequence identity among p460, AT, and MEC-1, suggesting that region B subserves an important function(s). Our analysis of the biochemical defects in scid p460 suggest that the 83 residues truncated by the scid mutation may regulate both p460 stability and subcellular localization. Alternatively, the decreased abundance of p460 in scid cells may be an indirect consequence of a primary defect in transport to, or retention within, the nuclear compartment.
Impact of defects in DNA-PK cs on the scid phenotype. Combined biochemical and genetic evidence suggests that DNA-PK regulates transcription and the cellular response to DNA damage and that its function is particularly important in the context of V(D)J recombination. A satisfactory explanation of the scid mutation will need to encompass several interesting features of the scid phenotype and may extend well beyond the roles of DNA-PK catalytic activity. V(D)J recombination generates signal ends and coding ends. Although signal joints are generated at relatively normal frequencies, "broken" coding ends accumulate and coding joint formation is seriously impaired in scid lymphocytes (37, 49, 63) . Nevertheless, multiple studies demonstrate that the scid mutation is leaky. Chromosomal DSB can be repaired in scid cells, though not as well as in WT cells (16) . In contrast to the complete blockade of V(D)J recombination in RAG-1-or RAG-2-deficient mice (40, 54) , normal immunoglobulin D/JH coding joints were found in scid bone marrow at 1 to 10% the WT frequency (43) . Moreover, oligoclonal T and B cells expressing cell surface TCRs and immunoglobulin receptors have been isolated from scid mice, signifying that rare clones produced three successful V(D)J coding joins (10, 34, 46, 62) . Collectively, these data are consistent with the idea that scid is not a null mutation in DNA-PK.
We have previously shown that both environmental and genetic manipulations of scid mice can enhance V(D)J recombination in scid thymocytes. Low-dose irradiation of newborn scid mice rapidly rescues V(D)J recombination at the TCR␤ and TCR␦ loci (6, 19, 38) . The mechanistic basis of this effect may involve DNA damage-induced rescue of scid p460 function or induction of an independent compensatory DNA repair activity. The evidence presented here demonstrates the expression of a potentially functional p460 molecule in scid lymphocyte precursors, leaving open the possibility that p460 is an essential participant in the radiation effect. Recently, we have demonstrated that V(D)J coding ends initiate a p53-mediated DNA damage checkpoint responsible for apoptotic elimination of scid lymphocytes. Ablation of this checkpoint in p53 Ϫ/Ϫ scid double-mutant mice prolonged cell survival, revealing a substantial, albeit not WT, capacity for V(D)J coding joint formation (26) . In concert with these in vivo data, the biochemical and genetic defects in p460 described here support the view that the scid phenotype issues from inefficient DSB repair, rather than absence of an activity.
